Microbe Species Information

General Information of This Microbe species
Species ID
MIC00037
Species Name
Lacticaseibacillus rhamnosus
Taxonomy ID
47715
Lineage
Kingdom: Bacteria
Phylum: Bacillota
Class: Bacilli
Order: Lactobacillales
Family: Lactobacillaceae
Genus: Lacticaseibacillus
Species: Lacticaseibacillus rhamnosus
Drug Transporter(s) Regulated by This Microbe species

Class4: Microbiota regulating the expression and function of DT via other mechanisms

MRP2

 Transporter Info

Diabetes [ICD11: 5A10-5A14]

 [1] , [2]

P-GP

 Transporter Info

Type 1 diabetes mellitus [ICD11: 5A10]

 [3]
Species Relative Abundances of This Microbe species
References
1 The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharm Sin B. 2021 Jul;11(7):1789-1812.
2 Probiotic Pre-treatment Reduces Gliclazide Permeation (ex vivo) in Healthy Rats but Increases It in Diabetic Rats to the Level Seen in Untreated Healthy Rats. Arch Drug Inf. 2008 Jul;1(1):35-41.
3 The gut microbiota contributes to the modulation of intestinal CYP3A1 and P-gp in streptozotocin-induced type 1 diabetic rats. Eur J Pharm Sci. 2021 Jul 1;162:105833.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.